Recombinant human N-acetylglucosamine-1-P uridyltransferase (AGX1), E. coli

Cat. No.: XET005Q

Recombinant human N-acetylglucosamine-1-P uridyltransferase (AGX1), E. coli

Synonym: AGX1; N-Acetylglucosamine-1-phosphate uridyltransferase

  • Enzyme Commission Number: 2.3.1.157
Product Size
5 units; 25 units; 50 units
Price
Datasheet
MSDS
Properties
Description
It is an recombinant human N-acetylglucosamine-1-P uridyltransferase (AGX1) produced in E. coli. This product can be used to study the mode of action of the enzyme and its potential inhibitors, and can also be used as a glycoengineering tool to modify glycoproteins in vitro.
Molecular Weight
25 KDa
Unit Definition
One unit will catalyze the formation of 1 μmol UDP-GlcNAc from GlcNAc-1-P and UTP per minute at 37°C.
Source
Homo sapien
Form
Lyophilized powder
Purity
>95%, determined by SDS-PAGE.
Applications
Study the mode of action of the enzyme and its potential inhibitors and as a glycoengineering tool to modify glycoproteins in vitro.
Safety Information
Personal Protective Equipment
Gloves, eyeshields, N95 mask
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0